WIA
ABBV icon

Wetzel Investment Advisors’s AbbVie ABBV Stock Holding History

Wetzel Investment Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$241K Sell
958
-30
-3% -$6.45K 0.08% 121
2026
Q1 		$215K Hold
988
– – 0.09% 129
2025
Q4 		$226K Sell
988
-46
-4% -$10.5K 0.09% 127
2025
Q3 		$239K Sell
1,034
-102
-9% -$20.8K 0.1% 117
2025
Q2 		$211K Buy
1,136
+38
+3% +$7.06K 0.1% 118
2025
Q1 		$230K Buy
+1,098
New +$213K 0.12% 107
2024
Q4 		– Sell
-1,132
Closed -$224K – 122
2024
Q3 		$224K Buy
1,132
+165
+17% +$30.8K 0.11% 112
2024
Q2 		$176K Sell
967
-123
-11% -$20.4K 0.1% 124
2024
Q1 		$179K Hold
1,090
– – 0.11% 121
2023
Q4 		$169K Buy
+1,090
New +$159K 0.1% 125

Other funds holding ABBV

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return
AAIS
ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return

Wetzel Investment Advisors's ABBV Position: Q2 2026 in Review

Wetzel Investment Advisors reduced its AbbVie (ABBV) stake by 3% in Q2 2026, selling an estimated $6.45K and leaving 958 shares worth $241K. The position accounts for 0.08% of the portfolio, ranked #121.

Wetzel Investment Advisors first reported a position in ABBV in Q4 2023 and has held it in 10 quarters since. 1,482 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Wetzel Investment Advisors held 958 shares of AbbVie worth $241K as of Q2 2026.
  • Wetzel Investment Advisors sold 30 AbbVie shares in Q2 2026, an estimated $6.45K.
  • AbbVie made up 0.08% of Wetzel Investment Advisors's portfolio in Q2 2026, its #121 holding.
  • Wetzel Investment Advisors first reported a position in AbbVie in Q4 2023 and has held it in 10 quarters since.
  • 1,482 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Wetzel Investment Advisors's 13F filing for Q2 2026, filed 23 Jul 2026.